1. Home
  2. BMM vs VALN Comparison

BMM vs VALN Comparison

Compare BMM & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMM

Blue Moon Metals Inc. Common Shares

N/A

Current Price

$4.87

Market Cap

545.3M

Sector

N/A

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$7.11

Market Cap

495.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMM
VALN
Founded
2007
2012
Country
Canada
France
Employees
68
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
545.3M
495.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BMM
VALN
Price
$4.87
$7.11
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
214.4K
26.9K
Earning Date
05-25-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.47
$4.75
52 Week High
$8.63
$12.25

Technical Indicators

Market Signals
Indicator
BMM
VALN
Relative Strength Index (RSI) 36.46 85.11
Support Level $4.85 $5.03
Resistance Level $6.53 $9.56
Average True Range (ATR) 0.44 0.19
MACD -0.02 0.18
Stochastic Oscillator 22.47 92.05

Price Performance

Historical Comparison
BMM
VALN

About BMM Blue Moon Metals Inc. Common Shares

Blue Moon Metals Inc is a Canadian exploration stage company focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The projects of the company include the Nussir copper-gold-silver property in Norway (the "Nussir Property"), the Blue Moon zinc-copper-gold-silver property in California, USA (the "Blue Moon Property"), the NSG copper-zinc-gold-silver property in Norway (the "NSG Property") the Springer tungsten-molybdenum project in the Nevada, USA (the "Springer Property") and the Apex germanium-gallium-copper project in Utah, USA (the "APEX Property").

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: